共 283 条
[1]
Bymaster FP(2005)The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression Curr Pharm Des 11 1475-93
[2]
Lee TC(2005)SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants CNS Spectr 10 732-47
[3]
Knadler MP(2006)Duloxetine: a new selective and dual-acting antidepressant Expert Opin Pharmacother 7 421-7
[4]
Stahl SM(2005)The medical management of depression N Engl J Med 353 1819-34
[5]
Grady MM(2003)Dual monoamine modulation for improved treatment of major depressive disorder J Clin Psychopharmacol 23 78-86
[6]
Moret C(1998)Specific serotonin and noradrenaline reuptake inhibitors (SNRIs): a review of their pharmacology, clinical efficacy and tolerability Hum Psychopharmacol 13 99-111
[7]
Bauer M(1993)LY248686, a new inhibitor of serotonin and norepinephrine uptake Neuropsychopharmacology 8 23-33
[8]
Moller HJ(2001)Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors Neuropsychopharmacology 25 871-80
[9]
Schneider E(2002)Duloxetine pharmacology: profile of a dual monoamine modulator CNS Drug Rev 8 361-76
[10]
Mann JJ(1998)Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test Psychopharmacology (Berl) 136 190-7